Chinese herbal medicine may improve outcomes after STEMI

CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and

Traditional Chinese medicine Tongxinluo may improve heart health

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

Myocardial infarction - Wikipedia

China is encouraging herbal remedies to treat COVID-19. But scientists warn against it.

Frontiers Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges

Frontiers Acceptability of Traditional Chinese Medicine in Chinese People Based on 10-Year's Real World Study With Mutiple Big Data Mining

Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis - ScienceDirect

Long-term cardiovascular outcomes of COVID-19

Chinese Medicine Tongxinluo Yields 'Surprising' Benefits Post-STEMI: CTS-AMI

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China

Chinese Medicine Tongxinluo Improves STEMI Outcomes, Sparks Debates - Cardiac Wire